United Kingdom· GB-APID-4520911000001100

Sustiva 100mg capsules

A efavirenz product containing efavirenz, registered in United Kingdom by Bristol-Myers Squibb Pharmaceuticals Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG03

Checked against NHS dm+d (United Kingdom) on September 13, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about efavirenzAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Efavirenz is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.

This record: United Kingdom, from NHS dm+d (United Kingdom)
9 of them publish a price we can compare per daily dose

Search efavirenz products by name

Efavirenz · ATC J05AG03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of efavirenz costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Efavirenz · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

FR France$66.82
CH Switzerland$9.90

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)

Active substance: Efavirenz
Manufacturer: Bristol-Myers Squibb Pharmaceuticals Ltd
Country: United Kingdom (GB)
ATC code: J05AG03
ATC class: Efavirenz
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: NHS dm+d (United Kingdom)
Last checked: September 13, 2026

Packs & prices · 1

gtin
5012712003045

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

486 interactions on record for efavirenz.

Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check efavirenz against other medicines How interaction checks work

Efavirenz · interactions on record

486 records

137 severe
278 moderate
8 minor
48 info

Most severe, free to view

CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe
DolasetronA04AA04severe

15 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Efavirenz in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Efavirenz Sandoz
Belgium · Efavirenz Viatris
Cyprus · Efavirenz Aurobindo
Germany · Efavirenz Aurobindo
Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
Estonia · Efavirenz Sandoz
Spain · Efavirenz Aurovitas
Finland · Efavirenz Aurobindo, Efavirenz Sandoz
France · Efavirenz Arrow, Efavirenz Sandoz
Iceland · Efavirenz Teva
Liechtenstein · Efavirenz Teva
Netherlands · Efavirenz Accord, Efavirenz Aurobindo
Norway · Efavirenz Sandoz, Efavirenz Teva
Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d74c4423-a6f2-4c73-b026-8f784eb6b3e7
GET /v1/drugs/d74c4423-a6f2-4c73-b026-8f784eb6b3e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4520911000001100",
  "desc": "Sustiva 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)",
  "form": "Oral capsule",
  "vpid": "41762011000001103",
  "source": "dmd",
  "vtm_id": "775735009",
  "strength": "100 mg",
  "substance": "Efavirenz",
  "ingredient": "Efavirenz",
  "supplier_code": "3145301000001104"
}

API reference MCP server Plans

See everything about efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console